Patients with IBD are known to have a deficiency in the activity of TGFβ1 which is thought to be due to increased levels of SMAD7, an intracellular protein that binds TGF-β1 receptor and prevents TGF-β1-associated and SMAD-associated signaling. The gene discussed is TGFB1; the disease is inflammatory bowel disease.